Ignite Creation Date:
2024-05-06 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05243524
Status:
TERMINATED
Last Update Posted:
2023-09-13
First Post:
2022-02-07
Brief Title:
Maveropepimut-S MVP-S and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer
Sponsor:
ImmunoVaccine Technologies Inc IMV Inc
Organization:
ImmunoVaccine Technologies Inc IMV Inc
Organization Data
Organization:
ImmunoVaccine Technologies Inc IMV Inc
Class:
INDUSTRY
Study ID:
P1606-SUR-O25
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ImmunoVaccine Technologies Inc IMV Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None